USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Analysis of the Global In Vitro Diagnostics Market
Analysis of the Global In Vitro Diagnostics Market
Slowing US and European Markets Demand Alignment with Global Market Needs
RELEASE DATE
22-Jul-2014
22-Jul-2014
REGION
North America
North America
Research Code: NE3E-01-00-00-00
SKU: LS00047-NA-MR_16888
$4,950.00
Special Price $3,712.50 save 25 %
In stock
SKU
LS00047-NA-MR_16888
Description
Despite global economic and industry challenges, in vitro diagnostics (IVD) markets are growing robustly at double the rate of the global pharmaceutical industry. The global IVD market size was $47.30 billion in 2013; it is expected to reach $62.63 billion in 2017, at a compound annual growth rate of 7.3%. Because of stagnating mature markets, companies are heavily focused on globalization in emerging economies such as China and Brazil. This research service discusses the IVD segments of immunochemistry, point-of-care testing, molecular diagnostics, clinical microbiology, tissue diagnostics, hematology, hemostasis, and self-monitoring blood glucose.
Table of Contents
Executive Summary
Executive Summary (continued)
Executive Summary (continued)
Scope and Segmentation
Key Questions This Study Will Answer
Market Engineering Measurements
CEO’s Perspective
Methodology
Market Overview—Definitions
Market Segmentation
Market Drivers
Drivers Explained
Drivers Explained (continued)
Drivers Explained (continued)
Drivers Explained (continued)
Market Restraints
Restraints Explained
Restraints Explained (continued)
Restraints Explained (continued)
Restraints Explained (continued)
Focus on Emerging Markets—Market Drivers
Focus on Emerging Markets—Market Restraints
Market Engineering Measurements
Market Engineering Measurements (continued)
Total IVD Market—Revenue Forecast
Revenue Forecast Discussion
Competitive Analysis—Market Share
Market Share Analysis
Competitive Environment
Competitive Factors—Mergers & Acquisitions
Immunochemistry Segment—Overview
Immunochemistry Segment—Market Engineering Measurements
Immunochemistry Segment—Revenue Forecast
Immunochemistry Segment—Revenue Forecast Discussion
Competitive Analysis—Market Share
Competitive Analysis—Market Share (continued)
Immunochemistry Segment—Competitive Environment
Immunochemistry Segment—Installed Base
Immunochemistry Segment—Product Analysis
Immunochemistry Segment—Product Analysis (continued)
Immunochemistry Segment—Product List
Immunochemistry Segment—Product List (continued)
Immunochemistry Segment—Product List (continued)
Immunochemistry Segment—Common Tests
Immunochemistry Segment—Common Tests (continued)
SMBG Segment—Overview
SMBG Segment—Market Engineering Measurements
SMBG Segment—Revenue Forecast
SMBG Segment—Revenue Forecast Discussion
Competitive Analysis—Market Share
Market Share Analysis
SMBG Segment—Competitive Environment
SMBG Segment—Product List
POCT Segment—Overview
POCT Segment—Market Engineering Measurements
POCT Segment—Revenue Forecast
POCT Segment—Revenue Forecast Discussion
Competitive Analysis—Market Share
Market Share Analysis
POCT Segment—Competitive Environment
Molecular Diagnostics Segment—Overview
Molecular Diagnostics Segment—Overview (continued)
Molecular Diagnostics Segment—Market Engineering Measurements
Molecular Diagnostics Segment—Revenue Forecast
Molecular Diagnostics Segment—Revenue Forecast Discussion
Competitive Analysis—Market Share
Market Share Analysis
Molecular Diagnostics Segment—Competitive Environment
Molecular Diagnostics Segment—Tests
Molecular Diagnostics Segment—Product List
Molecular Diagnostics Segment—Product List (continued)
Molecular Diagnostics Segment—Product List (continued)
Molecular Diagnostics Segment—Product List (continued)
Hematology Segment—Overview
Hematology Segment—Market Engineering Measurements
Hematology Segment—Revenue Forecast
Hematology Segment—Revenue Forecast Discussion
Competitive Analysis—Market Share
Market Share Analysis
Hematology Segment—Competitive Environment
Hematology Segment—Installed Base
Hematology Segment—Installed Base (continued)
Hematology Segment—Product List
Hematology Segment—Product List (continued)
Clinical Microbiology Segment—Overview
Clinical Microbiology Segment—Market Engineering Measurements
Clinical Microbiology Segment—Revenue Forecast
Clinical Microbiology Segment—Revenue Forecast Discussion
Competitive Analysis—Market Share
Market Share Analysis
Clinical Microbiology Segment—Competitive Environment
Clinical Microbiology Segment—Technology Trends
Hemostasis Segment—Overview
Hemostasis Segment—Market Engineering Measurements
Hemostasis Segment—Revenue Forecast
Hemostasis Segment—Revenue Forecast Discussion
Competitive Analysis—Market Share
Market Share Analysis
Hemostasis Segment—Competitive Environment
Hemostasis Segment—Tests
Hemostasis Segment—Product List
Hemostasis Segment—Product List (continued)
Tissue Diagnostics Segment Overview
Tissue Diagnostics Segment Overview (continued)
Tissue Diagnostics Segment—Market Engineering Measurements
Tissue Diagnostics Segment—Revenue Forecast
Tissue Diagnostics Segment—Revenue Forecast by Subsegment
Tissue Diagnostics Segment—Revenue Forecast Discussion
Competitive Analysis—Market Share
Competitive Analysis—Market Share (continued)
Competitive Structure
Total IVD Market—Percent Revenue Forecast by Region
Total IVD Market—Regional Growth
IVD Market—US Revenue Forecast
IVD Market—Western Europe Revenue Forecast
IVD Market—Asia-Pacific and China Revenue Forecast
IVD Market—Brazil Revenue Forecast
IVD Market—Eastern Europe Revenue Forecast
IVD Market—Rest of World Revenue Forecast
The Last Word—Three Big Predictions
The Last Word—Discussion
The Last Word—Discussion (continued)
Legal Disclaimer
List of Other Companies—Total Market Level
List of Other Companies—Segment Level
List of Other Companies—US Tissue Diagnostics Segment
Associated Multimedia
Associated Multimedia (continued)
Market Engineering Methodology
Learn More—Next Steps
Popular Topics
Despite global economic and industry challenges, in vitro diagnostics (IVD) markets are growing robustly at double the rate of the global pharmaceutical industry. The global IVD market size was $47.30 billion in 2013; it is expected to reach $62.63 billion in 2017, at a compound annual growth rate of 7.3%. Because of stagnating mature markets, companies are heavily focused on globalization in emerging economies such as China and Brazil. This research service discusses the IVD segments of immunochemistry, point-of-care testing, molecular diagnostics, clinical microbiology, tissue diagnostics, hematology, hemostasis, and self-monitoring blood glucose.
| No Index | No |
|---|---|
| Podcast | No |
| Lightbox Content | World Cancer Day 2019|Get 15% discount for all Healthcare studies |https://store.frost.com/contacts/?utm_source=PD&utm_medium=lightbox&utm_campaign=HEALTHCARE_CANCER2019 |
| Author | Divyaa Ravishankar |
| WIP Number | NE3E-01-00-00-00 |
| Is Prebook | No |